Ancell at 2017 AIC
Visit Ancell at booth T13 at the Autumn Immunology Conference Fri Nov 17 to Mon Nov 20th ! We are proud to fund an Undergrad Outreach Sponsorship, as well as a Wallace Diversity Sponsorship.
Ancell at 2017 AIC Read More »
Visit Ancell at booth T13 at the Autumn Immunology Conference Fri Nov 17 to Mon Nov 20th ! We are proud to fund an Undergrad Outreach Sponsorship, as well as a Wallace Diversity Sponsorship.
Ancell at 2017 AIC Read More »
“PD-1 Blockade Promotes Epitope Spreading in Anti-cnacer CD8+ T cell Reponses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination” Arash Memarnejadian, S M Mansour Haeryfar, et al. (Nov 2017) J Immunol 199(9): 3348-59. https://doi.org/10.4049/jimmunol.1700643. PMID: 28939757 Often over time, an anti-Cancer immune response narrows into a few dominant (high affinity) CD8+ T
An important anti Cancer mechanism of CD279(PD-1) blockade elucidated Read More »
New Ancell TIGIT-muIg binds to CD155 on U-937 cells and to recombinant CD155-muIg in EIA! The TIGIT – CD155 regulatory pathway is emerging as an important element of immune function. Studies using knockout mice demonstrate that this pathway is important in optimal NK effector cell function (activation and/or tolerance) (1) There is significant potential
Recombinant TIGIT Now Available! Read More »
The CD47 – along with its ligand, SIRP alpha are now recognized as an important regulatory element of innate immune function. (1). CD47 is described as a “don’t eat me” signal. However, it appears that CD47, along with Intraflagellar Transport Proteins 20 and 57 (IFT 20, IFT 57) are also involved in T cell receptor
CD47 important in TCR Immune synapse Read More »
CD268 (BAFF-R, TNFRSF13C) is a significant marker for B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL). Ancell clone ANC268.2 was used to phenotype patient samples. Blocking the BAFF – BAFFR pathway may prove to be useful in treating BCP-ALL. “TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic
The TIGIT – CD155 regulatory pathway is emerging as an important element of immune function. Studies using knockout mice demonstrate that this pathway is important in optimal NK effector cell function (activation and/or tolerance) (1) There is significant potential for the development of immunological drugs that could blockade this pathway, restoring anti-cancer immune response (2).
TIGIT – CD155 pathway Read More »
Please visit Ancell at booth #812 May 13 -15 at the AAI meetings in Washington DC!
Ancell at Immunology 2017 meetings in DC Read More »
“Endothelial Cell Inflammatory Reactions Are Altered in the Presence of E-Cigarette Extracts of Variable Nicotine” Barber, K.E., Ghebrehiwet, B., Yin, W. et al. (2017) Cel. Mol. Bioeng. 10: 124. doi:10.1007/s12195-016-0465-4 The Authors utilized an in vitro model in which HUVEC (human umbilical cord endothelial cells) were exposed to tobacco vapor/ in HEPES buffer to
Tobacco vapor causes endothelial cell inflammation regardless of nicotine content Read More »
An Ohio research group tested the efficacy of inactivated Swine Influenza virus (SwlV) encapsulated in 200–300 nm diameter PLGA (poly lactic co-glycolic acid) microspheres. Pigs were immunized twice intranasaly. While control pigs had fever for four days, treated pigs showed no clinical flu symptoms. “Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous
Nanoparticle based Flu vaccine shows promise in pig study Read More »
CD36 is a scavenger receptor which can bind to various ligands as well as long chain fatty acids. It plays a role in innate immunity as well as metabolism. The authors use transport inhibitors, and uptake of 14-C labeled Phosphate diester of alpha-Tocopheryl (Vitamin E ) to implicate the CD36/PI3Ky as an important pathway for
CD36/PI3Ky pathway identified for VEGF expression by monocytes Read More »